Compare Hecla Mining Company Common Stock (HL) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hecla Mining Company Common Stock vs Immunovant Inc. Common Stock — how do they compare? Hecla Mining Company Common Stock trades at $17.22 (market cap $11.24B), while Immunovant Inc. Common Stock trades at $30.27 (market cap $6.25B). The key difference: Hecla Mining Company Common Stock is the larger of the two by market cap, and Hecla Mining Company Common Stock pays a 0.09% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hecla Mining Company Common Stock for 0 Days and Immunovant Inc. Common Stock for 0 Days on average.
| HL | IMVT | |
|---|---|---|
Market Cap | $11.24B | $6.25B |
Volume | 37,227,749 | 1,755,411 |
Sector | Basic Materials | Health |
52-Week High | $31.81 | $44.96 |
52-Week Low | $11.97 | $17.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.77B | $5.35B |
Dividend Yield | 0.09% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hecla Mining Company Common Stock
Hecla Mining is a precious metals producer focused on silver and gold. It operates mines in the United States and Canada.
Read more on HL →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
